Seventure Partners has been investing in microbiome innovation since the launch of its 2014 Health for Life Fund and will now extend reach of its latest fund due to so much interest (Getty Images) European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin microbiome space.
Seventure Partners had been investing in microbiome innovation since the launch of its Health For Life Fund in 2014, where it invested €160m across 20 cutting-edge companies – Enterome, Vedanta Biosciences and BiomX, among others. In March 2019, Seventure Partners launched its Health For Life Fund II, making a further €200m+ available for investment in the microbiome and nutrition space – a fund that was recently extended.